“Rising Ethereum Fees: The Struggle is Real (and Relatable) – A Look at the Post-Dencun Paradox”

Despite the Dencun Update, Ethereum’s Revenue from Fees Surprisingly Grew in 2024! The Unexpected Growth It’s not every day that a software update intended to reduce transaction costs ends up increasing revenue, but that’s exactly what happened with Ethereum in 2024. The Dencun Update was rolled out with the goal of making transactions more affordable…

Read More

“Spice Up Your Earnings Knowledge: A Recap of McCormick & Company’s Q4 2024 Earnings Call”

Welcome to the McCormick & Company Q4 2024 Earnings Conference Call! Company Participants: Faten Freiha – Vice President, Investor Relations Brendan Foley – Chairman, President and Chief Executive Officer Marcos Gabriel – Executive Vice President and Chief Financial Officer Conference Call Participants: Andrew Lazar – Barclays Peter Galbo – Bank of America Alexia Howard –…

Read More

“FAT Brands Shares Exciting Update for Warrant Holders Regarding Twin Hospitality Spin-Off”

Embracing Change: A Fresh Perspective on FAT Brands’ Spin-off Introduction In a recent announcement on January 23, 2025, FAT (Fresh. Authentic. Tasty.) Brands Inc. (NASDAQ: FAT) revealed plans for a partial spin-off of its subsidiary, Twin Hospitality Group Inc. This move comes in the form of a special stock dividend to FAT Brands’ common stockholders,…

Read More

“Unlocking Hope: Vigil Neurosciences’ Alzheimer’s Treatment Shows Promising Safety Results, Set to Begin Mid-Stage Trial in Q3”

The Latest Breakthrough in Alzheimer’s Disease Treatment Exciting News from Vigil Neuroscience Inc. On Thursday, Vigil Neuroscience Inc. VIGL released data from its completed Phase 1 trial evaluating VG-3927 as a potential treatment for Alzheimer’s disease. Alzheimer’s disease is a devastating condition that affects millions of individuals worldwide. It is a progressive neurodegenerative disorder that…

Read More